Update
$IGC Pharma(IGC.US$ IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1! Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
